ICON & Boston Research Institute Form Alliance

The alliance will combine BCRI’s leadership in clinical strategy, study planning and academic relationships with ICON’s experience in the execution of global clinical trials.

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced yesterday its strategic alliance with Boston Clinical Research Institute (BCRI). The alliance will combine BCRI’s leadership in clinical strategy, study planning and academic relationships with ICON’s experience in the execution of global clinical trials.

BCRI,  an Academic Research Organization, provides scientific consultancy in study design using expert clinicians and key opinion leaders from premier medical institutions, and also maintains a network of global investigators in all of the medical specialties and subspecialties.